Drug agency Lupin immediately stated it has launched a generic model of Pennsaid, used to deal with ache within the knees attributable to osteoarthritis within the American market.
The corporate’s product — Diclofenac Sodium Topical Answer 2 per cent — is the generic model of Horizon Pharma Therapeutics Pennsaid, Lupin stated in a press release.
As per IQVIA MAT October 2022 knowledge, Lupin stated diclofenac sodium topical answer, 2 per cent, had estimated annual gross sales of $509 million within the US.
(Aside from the headline, this story has not been edited by NDTV workers and is printed from a syndicated feed.)
Featured Video Of The Day
What Market Watchers Say About China Unrest And The International Impression